JNGLX
Price
$63.64
Change
-$0.42 (-0.66%)
Updated
May 22 closing price
Net Assets
4.66B
LHCCX
Price
$16.72
Change
-$0.07 (-0.42%)
Updated
May 22 closing price
Net Assets
7.15M
Interact to see
Advertisement

JNGLX vs LHCCX

Header iconJNGLX vs LHCCX Comparison
Open Charts JNGLX vs LHCCXBanner chart's image
Janus Henderson Global Life Sciences D
Price$63.64
Change-$0.42 (-0.66%)
VolumeN/A
Net Assets4.66B
Lord Abbett Health Care C
Price$16.72
Change-$0.07 (-0.42%)
VolumeN/A
Net Assets7.15M
JNGLX vs LHCCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JNGLX vs. LHCCX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Buy and LHCCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.66B vs. LHCCX (7.15M). JNGLX pays higher dividends than LHCCX: JNGLX (0.34) vs LHCCX (0.00). JNGLX was incepted earlier than LHCCX: JNGLX (26 years) vs LHCCX (6 years). LHCCX (4.09) is less costly to investors than JNGLX (0.80). LHCCX is a more actively managed with annual turnover of: 88.00 vs. JNGLX (35.00). LHCCX has a lower initial minimum investment than JNGLX: LHCCX (1500) vs JNGLX (2500). LHCCX annual gain was more profitable for investors over the last year : -9.10 vs. JNGLX (-14.56). JNGLX return over 5 years is better than : 6.56 vs. LHCCX (-1.64).
JNGLXLHCCXJNGLX / LHCCX
Total Expense Ratio0.801.7845%
Annual Report Gross Expense Ratio0.804.0920%
Fund Existence26 years6 years-
Gain YTD-6.260-8.75072%
Front LoadN/AN/A-
Min. Initial Investment25001500167%
Min. Initial Investment IRAN/AN/A-
Net Assets4.66B7.15M65,132%
Annual Yield % from dividends0.340.00-
Returns for 1 year-14.56-9.10160%
Returns for 3 years5.574.42126%
Returns for 5 years6.56-1.64-400%
Returns for 10 years6.65N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JCVIX23.91N/A
N/A
JHancock Classic Value I
GTSRX22.00N/A
N/A
Invesco Small Cap Growth R
EMQCX8.15N/A
N/A
Ashmore Emerging Markets Active Eq C
FECMX40.59N/A
N/A
Fidelity Advisor Emerging Markets I
TSCGX16.85-0.04
-0.24%
Thrivent Small Cap Growth S